These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 9573676

  • 1. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
    Ribera JM, Ortega JJ, Oriol A, Fontanillas M, Hernández-Rivas JM, Brunet S, García-Conde J, Maldonado J, Zuazu J, Gardella S, Besalduch J, León P, Macià J, Domingo-Albós A, Feliu E, San Miguel JF.
    Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
    [Abstract] [Full Text] [Related]

  • 2. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ, Ribera JM, Oriol A, Bastida P, González ME, Calvo C, Egurbide I, Hernández Rivas JM, Rivas C, Alcalá A, Besalduch J, Maciá J, Gardella S, Carnero M, Lite JM, Casanova F, Martinez M, Fontanillas M, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas.
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [Abstract] [Full Text] [Related]

  • 4. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ, PETHEMA Group, Spain.
    Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571
    [Abstract] [Full Text] [Related]

  • 5. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.
    Martino R, Bellido M, Brunet S, Altés A, Sureda A, Guárdia R, Aventín A, Nomdedéu JF, Domingo-Albós A, Sierra J.
    Haematologica; 1999 Jun; 84(6):505-10. PubMed ID: 10366793
    [Abstract] [Full Text] [Related]

  • 6. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 7. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients].
    Jin FY, Zou DH, Wang GR, Xu Y, Feng SZ, Zhao YZ, Han MZ, Yan WW, Qiu LG.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):645-8. PubMed ID: 16620547
    [Abstract] [Full Text] [Related]

  • 9. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, Guyotat D, Berthou C, Casassus P, Baranger L, Béné MC, Ifrah N, Gyan E, GOELAMS Group.
    Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
    [Abstract] [Full Text] [Related]

  • 10. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
    Ho CL, Chen YC, Kao WY, Chao TY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
    [Abstract] [Full Text] [Related]

  • 11. Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
    Oriol A, Ribera JM, Esteve J, Sanz MA, Brunet S, Garcia-Boyero R, Fernández-Abellán P, Martí JM, Abella E, Sánchez-Delgado M, Peñarrubia MJ, Besalduch J, Moreno MJ, Borrego D, Feliu E, Ortega JJ, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2003 Apr; 88(4):445-53. PubMed ID: 12681972
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ.
    J Clin Oncol; 2008 Apr 10; 26(11):1843-9. PubMed ID: 18398150
    [Abstract] [Full Text] [Related]

  • 13. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
    Hutchinson RJ, Gaynon PS, Sather H, Bertolone SJ, Cooper HA, Tannous R, Wells LM, Heerema NA, Sailer S, Trigg ME, Children's Cancer Group/Children's Oncology Group.
    J Clin Oncol; 2003 May 01; 21(9):1790-7. PubMed ID: 12721256
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, Berger C, Schmitt C, Leblanc T, Cayuela JM, Socie G, Michel G, Leverger G, Baruchel A.
    J Clin Oncol; 2008 Mar 20; 26(9):1496-503. PubMed ID: 18349402
    [Abstract] [Full Text] [Related]

  • 15. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
    Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Gaynon PS.
    N Engl J Med; 1998 Jun 04; 338(23):1663-71. PubMed ID: 9614257
    [Abstract] [Full Text] [Related]

  • 16. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.
    Ann Hematol; 2004 Aug 04; 83(8):498-503. PubMed ID: 15156346
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of 71 adult acute lymphoblastic leukemia].
    Yoshida M, Kurata H, Tsunoda S, Iwama A, Suzuki T, Akutsu M, Imagawa S, Tsunoda J, Furukawa Y, Komatsu N.
    Gan To Kagaku Ryoho; 1993 Sep 04; 20(12):1827-33. PubMed ID: 8379676
    [Abstract] [Full Text] [Related]

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 04; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of chemotherapeutic results and prognostic factors of adult acute lymphoblastic leukemia].
    Fu MW, Mi YC, Qiu LG, Yu WJ, Lin D, Bian SG, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul 04; 29(7):435-40. PubMed ID: 19035173
    [Abstract] [Full Text] [Related]

  • 20. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
    Ribera JM, Ortega JJ, Oriol A, Bastida P, Calvo C, Pérez-Hurtado JM, González-Valentín ME, Martín-Reina V, Molinés A, Ortega-Rivas F, Moreno MJ, Rivas C, Egurbide I, Heras I, Poderós C, Martínez-Revuelta E, Guinea JM, del Potro E, Deben G.
    J Clin Oncol; 2007 Jan 01; 25(1):16-24. PubMed ID: 17194902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.